SlideShare una empresa de Scribd logo
1 de 46
APPROACH TO ASCITES
Approach To
Ascites
Presenter: NSANZABAGANWA Christian
University of Rwanda medical school
Ascites
üThe pathologic accumulation of fluid in the peritoneal cavity
üHealthy men have little or no intraperitoneal fluid
üWomen normally may have up to 20 mL depending on the phase of
the menstrual cycle.
Pathophysiology
Causes
Causes
Normal peritoneum
üPortal hypertension (75%)
üHypoalbuminemia
üMisceraneous
Diseased peritoneum
üInfections
üMalignancy
Ductal disruptions in trauma
Causes of ascites in normal peritonium
Causes of ascites in diseased peritonium
HISTORY
HISTORY
History of risk factors for liver disease
üLong term Alcohol consumption
üHistory of viral hepatitis (HBV&HCV) or jaundice
üMultiple sexual partners
üInjection drug use
üTransfusion with non-tested blood for hepatitis
NB: Donated blood screen for HBV began in 1972 in USA
and for HCV in 1992
üTattoos
History of long term stable cirrhosis who develop ascites: HCC is likely.
History of cancer or marked weight loss (malignant ascites).
NB: Malignant ascites is frequently painful vs Painless cirrhotic
ascites.
History of fevers: Bacterial peritonitis
Behavior and consciousness changes (encephalopathy)
History of Haemorrhoids/ Upper GI bleeding: Portal hypertension
History of TB or TB contact
Physical exam aims at diagnosing the cause
General appearance
üJaundice
üCachexia
üAnasarca
Upper limb
üFinger clubbing
üLiver flap
üLeukonikia
üPalmar erythema
Head
üPallor
üKayser-Fleischer ring
üPuffy eye
üLympadenopathies
üOral candidiasis
Physical exam
Neck
üVirchow node
üJVP distension
Chest
üGynecomastia
üSpider naevi
üAxillary hair loss
üDisplaced apex beat, Heave
üMurmar, gallop
Abdomen
üSigns of ascites ( distension,
shifting dullness)
üPuddle sign may be there when
fluid is 120 ml
üShifting dullness ≥ 500 ml
Abdomen
üDilated collateral veins
üSister Mary Joseph nodule
üHepatomegaly (can be hard,
tender or nodular, liver span)
üSplenomegaly
üTenderness
NB: It may be hard to palpate
the liver in huge ascites or in
cirrhosis
Stages
Stage 1+ is detectable only after careful examination.
Stage 2+ is easily detectable but of relatively small volume.
Stage 3+ is obvious ascites but not tense ascites.
Stage 4+ is tense ascites.
Investigations
1. Abdominal ultrasound establishes the presence of fluid
2. Diagnostic paracentesis
üTo determine the cause.
üPatient with cirrhosis and ascites or with clinical worsening to exclude
bacterial peritonitis
Inspection of ascitic fluid
üMost fluis is transparent and tinged yellow
üCloudy fluid suggests infection.
üMilky fluid in chylous ascites due to high triglyceride
üBloody fluid in traumatic paracentesis (It clots) and 20% of malignant
ascites (Doesn’t clot)
üStraw colored: Cirrhosis
üBile stained: Biliary contamination
Paracentesis
Routine studies
1. WBCs with differential. Normal <500 leukocytes/mcL &
<250(PMNs)/mcL.
üElevated WBCs in inflammatory condition
üPMN count of >250/mcL and >75% in bacterial peritonitis
üHigher WBCs predominance of lymphocytes in TB or peritoneal
carcinomatosis.
NB: Normal cell count: <500 WBCs/µL and <250 PMNs/ µL
2. Albumin and total protein
Serum ascitic albumin gradient (Serum albumin-ascitic
albumin)
üSAAG for the classification of ascites into portal hypertensive and
nonportal hypertensive causes.
üSAAG ≥ 1.1 g/dL suggests underlying portal hypertension,
üSAAG <1.1 g/dL implicate nonportal hypertensive causes.
üThe accuracy of the SAAG exceeds 95%
NB: 4% of patients have mixed ascites (cirrhosis portal
hypertension + malignancy or tuberculosis).
High SAAG does not exclude concomitant malignancy
üElevated SAAG with high protein (>2.5 g/dL): Hepatic congestion
üLow SAAG with high Protein: Malignant ascites
ü2/3 of malignant ascites have a total protein level>2.5 g/dL.
Culture and Gram stain
üTo detect bacterial peritonitis in neutrocytic ascites (>250 PMNs/µL)
üCulture detects bacteria with 92% sensitivity
üGram stain has 10% sensitivity
Ascitic fluid cytology: If peritoneal carcinomatosis is suspected:
56-75% Sensitive
Other lab studies
üAn elevated amylase: pancreatic ascites or GI perforation
üAscitic bilirubin > serum bilirubin: perforation of the biliary tree.
ü An elevated ascitic creatinine suggests leakage of urine
üAdenosine deaminase may be useful for the diagnosis TB peritonitis.
üGlucose: Low in TB peritonitis
üpH:<7 suggest bacterial infection
üRBCs: more than 50,000/µL suggests TB, malignancy or trauma
Imaging
üBoth ultrasound and CT imaging can distinguish between causes of
portal and nonportal hypertensive ascites.
üDoppler ultrasound and CT can detect Budd-Chiari syndrome.
Abdominal ultrasound
üConfirming the presence of ascites in smaller amount as small as 5-10
ml
üGuidance of paracentesis.
üIn patients with nonportal hypertensive ascites
üLymphadenopathy and the masses of liver, ovaries, and pancreas are
seen on U/S
CT-ScanUltrasound
Laparoscopy
Done in some patients for direct visualization to take biopsies of
üLiver
üPeritoneum (mesothelioma)
üIntra abdominal lymph nodes
Management
üAscites is not the diagnosis
üAlleviate symptomes
üManage and Treat the cause
Management
Diet: Dietary sodium restriction to 40 mmol (1 g in 24 hours).
Fluid restriction
üNot necessary unless the serum sodium is<120 mmol/L.
Diuretic therapy:
üStart if no response to sodium restriction
üSpironolactone: Starting at 100 mg daily, peak effect at 3days
üIf no response in a week, increase to Spironolactone 400 mg/day and
add Lasix 20-40mg 6-8 hrly to be 160mg/day
NB: Mainstay therapy for ascites is Diuretic therapy with
Spironolactone which helps eliminate sodium, antagonizes
hyperaldosteronism
üAmiloride 5–15 mg daily .
Monitoring
üCheck serum electrolytes (sodium levels) & creatinine at the start and
every other day
üMonitor weight of patients, input and output and abdominal girth
On diuretic, weight loss should be 300-500 g/d and 800-1000g/d
(patient with edema) and adjust diuretics as the ascites disappears
Electrolyte problems.
üDiuretics must betemporarily discontinued in rise in serum creatinine
level
üStop the diuretics & water restriction if the sodium < 120 mmol/L
üStop the diuretics if hyperkalaemia or encephalopathy occurs
Therapeutic Paracentesis
Done to relieve tense ascites or in refractory ascites
üHypovolemia can occur in fluid removal of ≥ 5L
üIV albumin is infused (8 g per L of ascitic fluid removed).
Refractory ascites
Refractory ascites refers to ascites that cannot be resolved by dietary
sodium restriction and diuretic treatment
1. Diuretic-resistant ascites: ascites that cannot be mobilized or its
recurrence cannot be prevented because of a lack of response to dietary
sodium restriction and intensive diuretic treatment.
2. Diuretic-intractable ascites: ascites that cannot be mobilized or its
early recurrence cannot be prevented because of the development of
diuretic-induced complications that preclude the use of an effective
diuretic dosage.
Risk factors to Refractory ascites
üWrong diuretics with only loop diuretics when their effect is
prevented by unopposed hyperaldosteronism
üNSAIDs inhibiting the synthesis of vasodilating renal prostaglandins
üACE inhibitors and angiotensin receptor antagonists, which can
impair the renal perfusion and reduce GFR in patients with cirrhosis
and ascites
üNephrotoxic drugs such as aminoglycosides
üComplications precipitating renal failure like vomiting, diarrhoea or
bleeding
üBacterial infections such as SBP
The International Ascites Club: Diagnostic
criteria
Treatment duration:
üDiuretic therapy (spironolactone 400 mg/day and furosemide 160
mg/day) for at least 1 week and on a salt-restricted diet of less 5.2 g of
salt/day without a response.
Lack of response:
üMean weight loss of <0.8 kg over 4 days and urinary sodium output
less than the sodium intake.
Early ascites recurrence:
üReappearance of grade 2 or 3 ascites within 4 weeks of initial
mobilization.
The International Ascites Club: Diagnostic
criteria
Diuretic-induced complications:
ü Diuretic-induced hepatic encephalopathy in the absence of any other
precipitating factor.
ü Diuretic-induced renal impairment: increase of serum creatinine by
>100% to a value >2 mg/dl in patients with ascites responding to
treatment.
ü Diuretic-induced hyponatraemia: decrease of serum sodium by >10
mmol/L to a serum sodium of <125 mmol/L.
ü Diuretic induced hypo or hyperkalaemia:to <3 mmol/L or >6 mmol/L
despite appropriate measures.
Prevention of refractory ascites
To restore responsiveness to the standard treatment.
üWithdrawal of the offending drug
üResolution of the complication
üAppropriate plasma volume expander if hypovolemic
Treatment of Refractory ascites
üRepeated large-volume paracentesis but it does not correct sodium
retention and ascites usually recurs
NB:
1. The first-line therapy of refractory ascites is large-volume
paracentesis adding albumin if >5 L of fluid are removed.
2. Routine ascitic PMNC count is recommended with each
paracentesis to detect SBP
Surgery for Refractory ascites
Implantation of the LeVeen shunt may offer better long-term control of
ascites but occlusion can occur
Transjugular intrahepatic portosystemic shunt (TIPS) is better than
large-volume paracentesis in the control of ascites
TIPS is done when
üLarge-volume paracentesis > 2/ month
üWhen ascites is loculated and cannot be
easily removed with a paracentesis
üThe patient becomes intolerant of repeated taps.
NB: Liver transplantation is the only improve the survival of
cirrhotic patients with refractory ascites
Surgery for Refractory ascites
LeVeen Shunt TIPS
SBP ( Spontaneous Bacterial Peritonitis)
Most common bacteria is E. Coli.
Bacteria are believed to gain access to peritoneum by hematogenous route.
Low ascitic fluid albumin (<1g/dl) predisposes to SBP
Clinical Presentation
üAbrupt onset of Fever,
üChills,
üGeneralized Abdominal Pain,
üRebound tenderness.
Labs
üAscitic Fluid analysis shows WBCs >500/mm3 and
neutrophil>250/mm3
Treat with
üCefotaxime 2 g every 8 h or ceftriaxone 2 g/day or
amoxicillin/clavulanate (1 g tid) for for at least 5 days
üWhen feasible, paracentesis should be repeated after 48 h to document
>25% decrease in PMNC count.
üIf not decreased, antibiotic should be changed according to the
bacterial susceptibility if cultures positive.
In Patients with elevated bilirubin (>4 mg/dl) and evidence of acute
renal dysfunction (defined as a BUN>30 mg/dl and
creatinine>1.0 mg/dl)
üGive albumin at days 1 and 3 of acute SBP therapy to prevent further
renal deterioration and improve survival
üAlbumin given is 1.5 g/kg on day 1 and 1 g/kg at day 3 up to a
maximum of 100 g/day.
Long-term antibiotic prophylaxis with oral norfloxacin (400 mg/day) for a
week is indicated in:
1. Patients with a prior history of SBP
2. Patients without a prior history of SBP but who:
ü have a low ascites protein (<1 g/dl) plus renal failure (creatinine
>1.2 mg/dl or BUN>25 mg/dl)
ü A serum sodium ≤130 mEq/L
ü Severe liver disease with serum bilirubin ≥3 mg/dl
Ciprofloxacin 750 mg once weekly can also be given prophylactically
Take home message
üAscites is not the diagnosis
üAlleviate symptoms
üManage and Treat the cause
üDetect SBP early and refractoriness and manage them
üEducate patients & relatives about risk factors of the causes ( eg:
Hepatitis treatment and prevention, early consult, less alcohol
consumption, etc…)
References
üUptodate
üCurrent medical diagnosis and treatment-2015
üDavidsons Principles and Practice of Medicine 22ed by Dr. Mahin
üOxford Handbook of Clinical Medicine (Oxford Handbook Series) by
Murray Longmore, Ian Wilkinson, Andrew Baldwin and Elizabeth
Wallin (Mar 9, 2014)
üUSMLE Step 2 CK Internal Medicine,2017
üHarrison's Principles of Internal Medicine, 18th ed.
üKumar & Clarks Medical Management and Therapeutics, Sep 21,
2011
TAKE PART IN A FIGHT FOR THE FUTURE

Más contenido relacionado

La actualidad más candente

Approach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) BleedingApproach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) BleedingArun Vasireddy
 
Gastroentrology Bleeding by dr Mohammed Hussien
Gastroentrology Bleeding by dr Mohammed HussienGastroentrology Bleeding by dr Mohammed Hussien
Gastroentrology Bleeding by dr Mohammed HussienKafrelsheiekh University
 
Diagnosis and Treatment of Ascites
Diagnosis and Treatment of AscitesDiagnosis and Treatment of Ascites
Diagnosis and Treatment of AscitesWaleed El-Refaey
 
Budd chiari syndrome
Budd chiari syndromeBudd chiari syndrome
Budd chiari syndromeGaurav Kumar
 
Approach to chronic diarrhoea
Approach to chronic diarrhoea Approach to chronic diarrhoea
Approach to chronic diarrhoea Abhinav Srivastava
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndromeAkshay Goel
 
Cirrhosis and Its Complications
Cirrhosis and Its ComplicationsCirrhosis and Its Complications
Cirrhosis and Its Complicationsozererik
 
Mesenteric ischemia/ Generalised abdominal pain
Mesenteric ischemia/  Generalised abdominal painMesenteric ischemia/  Generalised abdominal pain
Mesenteric ischemia/ Generalised abdominal painSelvaraj Balasubramani
 
Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)Pratap Tiwari
 
Upper Gastrointestinal bleeding
Upper Gastrointestinal bleedingUpper Gastrointestinal bleeding
Upper Gastrointestinal bleedingAmmar L. Aldwaf
 
Approach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundiceApproach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundiceSupreet Kumar
 
Esophageal varices
Esophageal varicesEsophageal varices
Esophageal varicesIRFAN UL HAQ
 
Epigastric pain differential diagnosis
Epigastric pain differential diagnosisEpigastric pain differential diagnosis
Epigastric pain differential diagnosisabdelrazekdawod
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failureSaqib Pervez
 

La actualidad más candente (20)

Upper GI Bleeding
Upper GI Bleeding Upper GI Bleeding
Upper GI Bleeding
 
Ascites
AscitesAscites
Ascites
 
Approach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) BleedingApproach to Management of Upper Gastrointestinal (GI) Bleeding
Approach to Management of Upper Gastrointestinal (GI) Bleeding
 
Gastroentrology Bleeding by dr Mohammed Hussien
Gastroentrology Bleeding by dr Mohammed HussienGastroentrology Bleeding by dr Mohammed Hussien
Gastroentrology Bleeding by dr Mohammed Hussien
 
Obscure GI Bleeding
Obscure GI BleedingObscure GI Bleeding
Obscure GI Bleeding
 
Diagnosis and Treatment of Ascites
Diagnosis and Treatment of AscitesDiagnosis and Treatment of Ascites
Diagnosis and Treatment of Ascites
 
Budd chiari syndrome
Budd chiari syndromeBudd chiari syndrome
Budd chiari syndrome
 
Approach to chronic diarrhoea
Approach to chronic diarrhoea Approach to chronic diarrhoea
Approach to chronic diarrhoea
 
Ascites mohamed sarhan
Ascites mohamed sarhanAscites mohamed sarhan
Ascites mohamed sarhan
 
Approach To a Patient with Ascitis
Approach To a Patient with AscitisApproach To a Patient with Ascitis
Approach To a Patient with Ascitis
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Cirrhosis and Its Complications
Cirrhosis and Its ComplicationsCirrhosis and Its Complications
Cirrhosis and Its Complications
 
Mesenteric ischemia/ Generalised abdominal pain
Mesenteric ischemia/  Generalised abdominal painMesenteric ischemia/  Generalised abdominal pain
Mesenteric ischemia/ Generalised abdominal pain
 
Chronic liver disease
Chronic liver diseaseChronic liver disease
Chronic liver disease
 
Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)Acute on Chronic Liver Failure (ACLF)
Acute on Chronic Liver Failure (ACLF)
 
Upper Gastrointestinal bleeding
Upper Gastrointestinal bleedingUpper Gastrointestinal bleeding
Upper Gastrointestinal bleeding
 
Approach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundiceApproach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundice
 
Esophageal varices
Esophageal varicesEsophageal varices
Esophageal varices
 
Epigastric pain differential diagnosis
Epigastric pain differential diagnosisEpigastric pain differential diagnosis
Epigastric pain differential diagnosis
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 

Similar a APPROACH TO DIAGNOSING AND MANAGING ASCITES

Ascites park022310
Ascites park022310Ascites park022310
Ascites park022310Romy Bode
 
APPROACH TO PATIENT WITH ASCITES.pptx
APPROACH TO PATIENT WITH ASCITES.pptxAPPROACH TO PATIENT WITH ASCITES.pptx
APPROACH TO PATIENT WITH ASCITES.pptxtesa10
 
diagnosisandtreatmentofascites-150118105509-conversion-gate01.pdf
diagnosisandtreatmentofascites-150118105509-conversion-gate01.pdfdiagnosisandtreatmentofascites-150118105509-conversion-gate01.pdf
diagnosisandtreatmentofascites-150118105509-conversion-gate01.pdfKemi Adaramola
 
Chronic liver disease for intense learning
Chronic liver disease for intense learningChronic liver disease for intense learning
Chronic liver disease for intense learningoneplus9rns
 
Cirrhosis complications
Cirrhosis complicationsCirrhosis complications
Cirrhosis complicationsPraveen Maurya
 
Ascites ( Diagnosis and management ).pdf
Ascites ( Diagnosis and management ).pdfAscites ( Diagnosis and management ).pdf
Ascites ( Diagnosis and management ).pdfMohamed Wifi
 
Portal hypertension, liver cirrhosis and liver transplant
Portal hypertension, liver cirrhosis and liver transplantPortal hypertension, liver cirrhosis and liver transplant
Portal hypertension, liver cirrhosis and liver transplantAnshu Yadav
 
Management of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related ComplicationsManagement of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related ComplicationsAhmed Adel
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.Shaikhani.
 
Detaliled approach to ascitic patients in liver cirrhosis
Detaliled approach  to ascitic patients in liver cirrhosisDetaliled approach  to ascitic patients in liver cirrhosis
Detaliled approach to ascitic patients in liver cirrhosiscardilogy
 
Upper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal BleedingUpper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal BleedingAbdullah Mamun
 
The seminar presentation on theUGIB.pptx
The seminar presentation on theUGIB.pptxThe seminar presentation on theUGIB.pptx
The seminar presentation on theUGIB.pptxBilisumaTAyana
 
GIT12.pdf
GIT12.pdfGIT12.pdf
GIT12.pdfkm30730
 
VARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSION
VARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSIONVARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSION
VARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSIONArkaprovo Roy
 
GIT j club cirrhosis16.
GIT j club cirrhosis16.GIT j club cirrhosis16.
GIT j club cirrhosis16.Shaikhani.
 

Similar a APPROACH TO DIAGNOSING AND MANAGING ASCITES (20)

Ascites park022310
Ascites park022310Ascites park022310
Ascites park022310
 
APPROACH TO PATIENT WITH ASCITES.pptx
APPROACH TO PATIENT WITH ASCITES.pptxAPPROACH TO PATIENT WITH ASCITES.pptx
APPROACH TO PATIENT WITH ASCITES.pptx
 
diagnosisandtreatmentofascites-150118105509-conversion-gate01.pdf
diagnosisandtreatmentofascites-150118105509-conversion-gate01.pdfdiagnosisandtreatmentofascites-150118105509-conversion-gate01.pdf
diagnosisandtreatmentofascites-150118105509-conversion-gate01.pdf
 
Chronic liver disease for intense learning
Chronic liver disease for intense learningChronic liver disease for intense learning
Chronic liver disease for intense learning
 
Cirrhosis complications
Cirrhosis complicationsCirrhosis complications
Cirrhosis complications
 
Portal hypertension
Portal hypertensionPortal hypertension
Portal hypertension
 
Ascites ( Diagnosis and management ).pdf
Ascites ( Diagnosis and management ).pdfAscites ( Diagnosis and management ).pdf
Ascites ( Diagnosis and management ).pdf
 
Portal hypertension, liver cirrhosis and liver transplant
Portal hypertension, liver cirrhosis and liver transplantPortal hypertension, liver cirrhosis and liver transplant
Portal hypertension, liver cirrhosis and liver transplant
 
Management of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related ComplicationsManagement of Cirrhotic Ascites and its Related Complications
Management of Cirrhotic Ascites and its Related Complications
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.
 
ACUTE PANCREATITIS.pptx
ACUTE PANCREATITIS.pptxACUTE PANCREATITIS.pptx
ACUTE PANCREATITIS.pptx
 
Detaliled approach to ascitic patients in liver cirrhosis
Detaliled approach  to ascitic patients in liver cirrhosisDetaliled approach  to ascitic patients in liver cirrhosis
Detaliled approach to ascitic patients in liver cirrhosis
 
Upper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal BleedingUpper Gastro-Intestinal Bleeding
Upper Gastro-Intestinal Bleeding
 
Liver cirrhosis
Liver cirrhosisLiver cirrhosis
Liver cirrhosis
 
Git bleeding 2
Git bleeding 2Git bleeding 2
Git bleeding 2
 
The seminar presentation on theUGIB.pptx
The seminar presentation on theUGIB.pptxThe seminar presentation on theUGIB.pptx
The seminar presentation on theUGIB.pptx
 
GIT12.pdf
GIT12.pdfGIT12.pdf
GIT12.pdf
 
VARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSION
VARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSIONVARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSION
VARICEAL HAEMORRHAGE WITH SPECIAL ATTENTION TO PORTAL HYPERTENSION
 
Upper GI bleeding
Upper GI bleedingUpper GI bleeding
Upper GI bleeding
 
GIT j club cirrhosis16.
GIT j club cirrhosis16.GIT j club cirrhosis16.
GIT j club cirrhosis16.
 

Último

Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 

Último (20)

Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 

APPROACH TO DIAGNOSING AND MANAGING ASCITES

  • 2. Approach To Ascites Presenter: NSANZABAGANWA Christian University of Rwanda medical school
  • 3. Ascites üThe pathologic accumulation of fluid in the peritoneal cavity üHealthy men have little or no intraperitoneal fluid üWomen normally may have up to 20 mL depending on the phase of the menstrual cycle.
  • 6. Causes Normal peritoneum üPortal hypertension (75%) üHypoalbuminemia üMisceraneous Diseased peritoneum üInfections üMalignancy Ductal disruptions in trauma
  • 7. Causes of ascites in normal peritonium
  • 8. Causes of ascites in diseased peritonium
  • 10. HISTORY History of risk factors for liver disease üLong term Alcohol consumption üHistory of viral hepatitis (HBV&HCV) or jaundice üMultiple sexual partners üInjection drug use üTransfusion with non-tested blood for hepatitis NB: Donated blood screen for HBV began in 1972 in USA and for HCV in 1992 üTattoos
  • 11. History of long term stable cirrhosis who develop ascites: HCC is likely. History of cancer or marked weight loss (malignant ascites). NB: Malignant ascites is frequently painful vs Painless cirrhotic ascites.
  • 12. History of fevers: Bacterial peritonitis Behavior and consciousness changes (encephalopathy) History of Haemorrhoids/ Upper GI bleeding: Portal hypertension History of TB or TB contact
  • 13. Physical exam aims at diagnosing the cause General appearance üJaundice üCachexia üAnasarca Upper limb üFinger clubbing üLiver flap üLeukonikia üPalmar erythema Head üPallor üKayser-Fleischer ring üPuffy eye üLympadenopathies üOral candidiasis
  • 14. Physical exam Neck üVirchow node üJVP distension Chest üGynecomastia üSpider naevi üAxillary hair loss üDisplaced apex beat, Heave üMurmar, gallop Abdomen üSigns of ascites ( distension, shifting dullness) üPuddle sign may be there when fluid is 120 ml üShifting dullness ≥ 500 ml
  • 15. Abdomen üDilated collateral veins üSister Mary Joseph nodule üHepatomegaly (can be hard, tender or nodular, liver span) üSplenomegaly üTenderness NB: It may be hard to palpate the liver in huge ascites or in cirrhosis
  • 16.
  • 17. Stages Stage 1+ is detectable only after careful examination. Stage 2+ is easily detectable but of relatively small volume. Stage 3+ is obvious ascites but not tense ascites. Stage 4+ is tense ascites.
  • 18. Investigations 1. Abdominal ultrasound establishes the presence of fluid 2. Diagnostic paracentesis üTo determine the cause. üPatient with cirrhosis and ascites or with clinical worsening to exclude bacterial peritonitis
  • 19. Inspection of ascitic fluid üMost fluis is transparent and tinged yellow üCloudy fluid suggests infection. üMilky fluid in chylous ascites due to high triglyceride üBloody fluid in traumatic paracentesis (It clots) and 20% of malignant ascites (Doesn’t clot) üStraw colored: Cirrhosis üBile stained: Biliary contamination
  • 21. Routine studies 1. WBCs with differential. Normal <500 leukocytes/mcL & <250(PMNs)/mcL. üElevated WBCs in inflammatory condition üPMN count of >250/mcL and >75% in bacterial peritonitis üHigher WBCs predominance of lymphocytes in TB or peritoneal carcinomatosis. NB: Normal cell count: <500 WBCs/µL and <250 PMNs/ µL
  • 22. 2. Albumin and total protein Serum ascitic albumin gradient (Serum albumin-ascitic albumin) üSAAG for the classification of ascites into portal hypertensive and nonportal hypertensive causes. üSAAG ≥ 1.1 g/dL suggests underlying portal hypertension, üSAAG <1.1 g/dL implicate nonportal hypertensive causes. üThe accuracy of the SAAG exceeds 95% NB: 4% of patients have mixed ascites (cirrhosis portal hypertension + malignancy or tuberculosis). High SAAG does not exclude concomitant malignancy
  • 23. üElevated SAAG with high protein (>2.5 g/dL): Hepatic congestion üLow SAAG with high Protein: Malignant ascites ü2/3 of malignant ascites have a total protein level>2.5 g/dL. Culture and Gram stain üTo detect bacterial peritonitis in neutrocytic ascites (>250 PMNs/µL) üCulture detects bacteria with 92% sensitivity üGram stain has 10% sensitivity Ascitic fluid cytology: If peritoneal carcinomatosis is suspected: 56-75% Sensitive
  • 24. Other lab studies üAn elevated amylase: pancreatic ascites or GI perforation üAscitic bilirubin > serum bilirubin: perforation of the biliary tree. ü An elevated ascitic creatinine suggests leakage of urine üAdenosine deaminase may be useful for the diagnosis TB peritonitis. üGlucose: Low in TB peritonitis üpH:<7 suggest bacterial infection üRBCs: more than 50,000/µL suggests TB, malignancy or trauma
  • 25. Imaging üBoth ultrasound and CT imaging can distinguish between causes of portal and nonportal hypertensive ascites. üDoppler ultrasound and CT can detect Budd-Chiari syndrome. Abdominal ultrasound üConfirming the presence of ascites in smaller amount as small as 5-10 ml üGuidance of paracentesis. üIn patients with nonportal hypertensive ascites üLymphadenopathy and the masses of liver, ovaries, and pancreas are seen on U/S
  • 27. Laparoscopy Done in some patients for direct visualization to take biopsies of üLiver üPeritoneum (mesothelioma) üIntra abdominal lymph nodes
  • 28. Management üAscites is not the diagnosis üAlleviate symptomes üManage and Treat the cause
  • 29. Management Diet: Dietary sodium restriction to 40 mmol (1 g in 24 hours). Fluid restriction üNot necessary unless the serum sodium is<120 mmol/L. Diuretic therapy: üStart if no response to sodium restriction üSpironolactone: Starting at 100 mg daily, peak effect at 3days üIf no response in a week, increase to Spironolactone 400 mg/day and add Lasix 20-40mg 6-8 hrly to be 160mg/day NB: Mainstay therapy for ascites is Diuretic therapy with Spironolactone which helps eliminate sodium, antagonizes hyperaldosteronism
  • 30. üAmiloride 5–15 mg daily . Monitoring üCheck serum electrolytes (sodium levels) & creatinine at the start and every other day üMonitor weight of patients, input and output and abdominal girth On diuretic, weight loss should be 300-500 g/d and 800-1000g/d (patient with edema) and adjust diuretics as the ascites disappears
  • 31. Electrolyte problems. üDiuretics must betemporarily discontinued in rise in serum creatinine level üStop the diuretics & water restriction if the sodium < 120 mmol/L üStop the diuretics if hyperkalaemia or encephalopathy occurs Therapeutic Paracentesis Done to relieve tense ascites or in refractory ascites üHypovolemia can occur in fluid removal of ≥ 5L üIV albumin is infused (8 g per L of ascitic fluid removed).
  • 32. Refractory ascites Refractory ascites refers to ascites that cannot be resolved by dietary sodium restriction and diuretic treatment 1. Diuretic-resistant ascites: ascites that cannot be mobilized or its recurrence cannot be prevented because of a lack of response to dietary sodium restriction and intensive diuretic treatment. 2. Diuretic-intractable ascites: ascites that cannot be mobilized or its early recurrence cannot be prevented because of the development of diuretic-induced complications that preclude the use of an effective diuretic dosage.
  • 33. Risk factors to Refractory ascites üWrong diuretics with only loop diuretics when their effect is prevented by unopposed hyperaldosteronism üNSAIDs inhibiting the synthesis of vasodilating renal prostaglandins üACE inhibitors and angiotensin receptor antagonists, which can impair the renal perfusion and reduce GFR in patients with cirrhosis and ascites üNephrotoxic drugs such as aminoglycosides üComplications precipitating renal failure like vomiting, diarrhoea or bleeding üBacterial infections such as SBP
  • 34. The International Ascites Club: Diagnostic criteria Treatment duration: üDiuretic therapy (spironolactone 400 mg/day and furosemide 160 mg/day) for at least 1 week and on a salt-restricted diet of less 5.2 g of salt/day without a response. Lack of response: üMean weight loss of <0.8 kg over 4 days and urinary sodium output less than the sodium intake. Early ascites recurrence: üReappearance of grade 2 or 3 ascites within 4 weeks of initial mobilization.
  • 35. The International Ascites Club: Diagnostic criteria Diuretic-induced complications: ü Diuretic-induced hepatic encephalopathy in the absence of any other precipitating factor. ü Diuretic-induced renal impairment: increase of serum creatinine by >100% to a value >2 mg/dl in patients with ascites responding to treatment. ü Diuretic-induced hyponatraemia: decrease of serum sodium by >10 mmol/L to a serum sodium of <125 mmol/L. ü Diuretic induced hypo or hyperkalaemia:to <3 mmol/L or >6 mmol/L despite appropriate measures.
  • 36. Prevention of refractory ascites To restore responsiveness to the standard treatment. üWithdrawal of the offending drug üResolution of the complication üAppropriate plasma volume expander if hypovolemic
  • 37. Treatment of Refractory ascites üRepeated large-volume paracentesis but it does not correct sodium retention and ascites usually recurs NB: 1. The first-line therapy of refractory ascites is large-volume paracentesis adding albumin if >5 L of fluid are removed. 2. Routine ascitic PMNC count is recommended with each paracentesis to detect SBP
  • 38. Surgery for Refractory ascites Implantation of the LeVeen shunt may offer better long-term control of ascites but occlusion can occur Transjugular intrahepatic portosystemic shunt (TIPS) is better than large-volume paracentesis in the control of ascites TIPS is done when üLarge-volume paracentesis > 2/ month üWhen ascites is loculated and cannot be easily removed with a paracentesis üThe patient becomes intolerant of repeated taps. NB: Liver transplantation is the only improve the survival of cirrhotic patients with refractory ascites
  • 39. Surgery for Refractory ascites LeVeen Shunt TIPS
  • 40. SBP ( Spontaneous Bacterial Peritonitis) Most common bacteria is E. Coli. Bacteria are believed to gain access to peritoneum by hematogenous route. Low ascitic fluid albumin (<1g/dl) predisposes to SBP Clinical Presentation üAbrupt onset of Fever, üChills, üGeneralized Abdominal Pain, üRebound tenderness.
  • 41. Labs üAscitic Fluid analysis shows WBCs >500/mm3 and neutrophil>250/mm3 Treat with üCefotaxime 2 g every 8 h or ceftriaxone 2 g/day or amoxicillin/clavulanate (1 g tid) for for at least 5 days üWhen feasible, paracentesis should be repeated after 48 h to document >25% decrease in PMNC count. üIf not decreased, antibiotic should be changed according to the bacterial susceptibility if cultures positive.
  • 42. In Patients with elevated bilirubin (>4 mg/dl) and evidence of acute renal dysfunction (defined as a BUN>30 mg/dl and creatinine>1.0 mg/dl) üGive albumin at days 1 and 3 of acute SBP therapy to prevent further renal deterioration and improve survival üAlbumin given is 1.5 g/kg on day 1 and 1 g/kg at day 3 up to a maximum of 100 g/day.
  • 43. Long-term antibiotic prophylaxis with oral norfloxacin (400 mg/day) for a week is indicated in: 1. Patients with a prior history of SBP 2. Patients without a prior history of SBP but who: ü have a low ascites protein (<1 g/dl) plus renal failure (creatinine >1.2 mg/dl or BUN>25 mg/dl) ü A serum sodium ≤130 mEq/L ü Severe liver disease with serum bilirubin ≥3 mg/dl Ciprofloxacin 750 mg once weekly can also be given prophylactically
  • 44. Take home message üAscites is not the diagnosis üAlleviate symptoms üManage and Treat the cause üDetect SBP early and refractoriness and manage them üEducate patients & relatives about risk factors of the causes ( eg: Hepatitis treatment and prevention, early consult, less alcohol consumption, etc…)
  • 45. References üUptodate üCurrent medical diagnosis and treatment-2015 üDavidsons Principles and Practice of Medicine 22ed by Dr. Mahin üOxford Handbook of Clinical Medicine (Oxford Handbook Series) by Murray Longmore, Ian Wilkinson, Andrew Baldwin and Elizabeth Wallin (Mar 9, 2014) üUSMLE Step 2 CK Internal Medicine,2017 üHarrison's Principles of Internal Medicine, 18th ed. üKumar & Clarks Medical Management and Therapeutics, Sep 21, 2011
  • 46. TAKE PART IN A FIGHT FOR THE FUTURE